Table 3 Clinical characteristics of the VTE and non-VTE groups

Age^a, yeas, mean ± SD

(range)

52.37 ± 11.35

(33–77)

55.27 ± 10.24

(29–83)

−0.448

0.655

BMI^b(kg/m²)

(range)

24.656 ± 5.09

(13.1–31.8)

24.299 ± 4.96

(13.1–34.1)

−0.375

0.707

Smoke or not^b, n(%)

2(22.22%)

15(10%)

1.328

0.247

FIGO stage^b, n(%)

1.872

0.596

I

1(11.11%)

38(25.33%)

II

2(22.22%)

43(28.67%)

III

3(33.33%)

41(27.33%)

IV

3(33.33%)

28(18.67%)

Adjuvant chemotherapy^b, n(%)

5(55.56%)

25(16.67%)

7.025

0.019

Pathological pattern^b, n(%)

1.910

0.403

Squamous cell

6(66.67%)

121(80.67%)

Adenocarcinoma

2(22.22%)

22(14.67%)

Adenosquamous

1(11.11%)

6(4%)

Other

0(0%)

1(0.67%)

Cervical cancer tumor size^b, n(%)

6.920

0.016

≥ 50 mm

6(66.67%)

39(26%)

< 50 mm

3(33.33%)

111(74%)